Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Vossen, Jaak M ^a   Guiot, Harry F L ^a   Lankester, Arjan C ^a   Vossen, Ann C T M ^a   Bredius, Robbert G M ^a   Wolterbeek, Ron ^a   Bakker, Hanny D J ^a   Heidt, Peter J ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; BUSULFAN; CEFALORIDINE; CEFTRIAXONE; CEFUROXIME; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; GENTAMICIN; HLA ANTIGEN; METHOTREXATE; PATTERN RECOGNITION RECEPTOR; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADOLESCENT; AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASEPSIS; CAPILLARY LEAK SYNDROME; CAUSE OF DEATH; CHILD; CHRONIC MYELOID LEUKEMIA; CYTOMEGALOVIRUS; DENDRITIC CELL; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FEMALE; GASTROINTESTINAL STERILIZATION; GRAFT RECIPIENT; HERPES VIRUS; HUMAN; INFANT; INTESTINE FLORA; INVASIVE ASPERGILLOSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; ORGAN DONOR; OVERALL SURVIVAL; PATIENT CARE; PRESCHOOL CHILD; RECURRENCE FREE SURVIVAL; RISK FACTOR; SCHOOL CHILD; STEVENS JOHNSON SYNDROME; VARICELLA ZOSTER VIRUS; VEIN OCCLUSION; VIRUS REACTIVATION; WHOLE BODY RADIATION; ADVERSE EFFECTS; ALLOTRANSPLANTATION; BLOOD; BONE MARROW TRANSPLANTATION; COMMUNICABLE DISEASE; COMPLICATION; DISEASE FREE SURVIVAL; DONOR; EPIDEMIOLOGY; GASTROINTESTINAL TRACT; GRAFT VS HOST DISEASE; MICROBIOLOGY; MICROFLORA; MORTALITY; SIBLING; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; CHILD; COMMUNICABLE DISEASES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL TRACT; GRAFT VS HOST DISEASE; HUMANS; MALE; MICROBIOTA; SIBLINGS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84907464665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105706     Document Type: Article

References (48)

1. Leung WH, Turner V, Richardson SL, Benaim E, Hale G, et al. (2001) Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors. Human Immunol 62: 399-407. (Pubitemid 32298983)
2. Martin P, Bleyzac N, Souillet G, Galambrun C, Bertrand Y, et al. (2003) Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors. Bone Marrow Transplant 32: 881-887. (Pubitemid 37369265)
3. Auletta JJ, Cooke KR (2009) Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease. Curr Opin Pediatr 21: 30-38.
4. Jones JM, Wilson R, Bealmear PM (1971) Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras by modification of the intestinal microflora. Radiat Res 45: 577-580.
5. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D (1974) Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 52: 401-404.
6. Vriesendorp HM, Heidt PJ, Zurcher C (1981) Gastrointestinal decontamination of dogs treated with total body irradiation and bone marrow transplantation. Exp Hematol 9: 904-916. (Pubitemid 13175969)
7. Heidt PJ, Wagemaker G, Timmermans CPJ, de Groot CW, van Bekkum DW (1996) Influence of gastrointestinal decontamination on graft-versus-host disease in rhesus monkeys after (partially) mismatched allogeneic bone marow transplantation. Microecol Ther 22: 89-106.
8. Vossen JM, Heidt PJ, van den Berg H, Gerritsen EJ, Hermans J, et al. (1990) Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 9: 14-23. (Pubitemid 20046730)
9. Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373: 1550-1561.
10. Vossen JM, van der Waaij D (1972) Reverse isolation in bone marrow transplantation: ultra-clean room compared with laminar flow technique. I. Isolation systems. Rev Eur Etud Clin Biol 17: 457-461.
11. Vossen J, Heidt P (1990) Gnotobiotic measure for the prevention of acute graft-vs.-host disease. In: Burakoff S, Ferarra J, Deeg H, Atkinson K, editors. Graft-vs.-host disease: Immunology, pathophysiology and treatment. New York, Basel: Marcel Dekker, Inc. pp. 403-413.
12. Heidt P, van der Waaij D, Vossen J, Hendriks W (1981) Recontamination following antibiotic decontamination: restoration of colonization resistance. Microecol Ther 11: 71-82.
13. Blom M, Meyer A, Gerner-Smidt P, Gaarslev K, Espersen F (1999) Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol 37: 2312-2316. (Pubitemid 29277797)
14. Kalpoe JS, Kroes ACM, de Jong MD, Schinkel J, de Brouwer CS, et al. (2004) Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 42: 1498-1504. (Pubitemid 38500787)
15. van Tol MJ, Kroes AC, Schinkel J, Dinkelaar W, Claas EC, et al. (2005) Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant 36: 39-50. (Pubitemid 40946049)
16. Gerritsen E, Stam E, Hermans J, van den Berg H, Haraldsson A, et al. (1996) Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children. Bone Marrow Transplant 18: 377-382. (Pubitemid 26283689)
17. Przepiorka D, Weisdorf D, Martin P, Klingemann H, Beatty P, et al. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15: 825-828.
18. Gale R, Bortin M, van Bekkum D, Biggs J, Dicke K, et al. (1987) Risk factors for acute graft-versus-host disease. Br J Haematol 67: 397-406. (Pubitemid 18032036)
19. Heit H, Wilson R, Fliedner T, Kohne E (1973) Mortality of secondary disease in antibiotic treated mouse radiation chimeras. In: Heneghan J, editor. Germfree research: biological effects of gnotobiotic environments. New York: Academic Press pp. 477-483.
20. Vossen J, Heidt P, Guiot H, Dooren L (1981) Prevention of acute graft versus host disease in clinical bone marrow transplantation: complete versus selective intestinal decontamination. In: Sasaki S, Osawa A, Hashimoto K, editors. Recent advances in germfree research. Tokyo: Tokai University Press. pp. 573-577.
21. Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, et al. (1983) Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 308: 302-307. (Pubitemid 13179412)
22. Beelen D, Haralambie E, Brandt H, Linzenmeier G, Müller K, et al. (1992) Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood 80: 2668-2676.
23. Storb R, Thomas ED (1985) Graft-versus-host disease in dog and man: the Seattle experience. Immunol Rev 88: 215-238. (Pubitemid 16172498)
24. Beelen D, Elmaagacli A, Müller K, Hirche H, Schaefer U (1999) Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin aloneon the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term-follow-up of an open-label prospective randomized trial. Blood 10: 3267-3275. (Pubitemid 29220893)
25. Alexander J, Boyce S, Babcock G, Gianotti L, Peck M, et al. (1990) The process of microbial translocation. Ann Surg 212: 496-510.
26. Fegan C, Poynton CH, Whittaker JA (1990) The gut mucosal barrier in bone marrow transplantation. Bone Marrow Transplant 5: 373-377. (Pubitemid 20344118)
27. Nejdfors P, Ekelund M, Weström B, Willén R, Jeppsson B (2000) Intestinal permeability in humans is increased after radiation therapy. Dis Colon Rectum 43: 1582-1588.
28. Johansson J, Ekman T (2007) Gut toxicity during hemopoietic stem cell transplantation may predict acute graft-versus-host disease severity in patients. Dig Dis Sci 52: 2340-2345.
29. Medzhitov R (2007) Recognition of microorganisms and activations of the immune response. Nature 449: 819-826.
30. Penack O, Holler E, van den Brink MR (2010) Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood 115: 1865-1872.
31. Murphy S, Nguyen VH (2011) Role of gut microbiota in graft-versus-host disease. Leuk Lymphoma 52: 1844-1856.
32. Gratama JW, Zwaan FE, Stijnen T, Weijers TF, Weiland HT, et al. (1987) Herpes-virus immunity and acute graft-versus-host disease. Lancet 1: 471-474. (Pubitemid 17036513)
33. Boström L, Ringdén O, Sundberg B, Linde A, Tollemar J, et al. (1988) Pretransplant herpesvirus serology and acute graft-versus-host disease. Transplantation 46: 548-545.
34. Broers AE, van Der Holt R, van Esser JW, Gratama JW, Henzen-Logmans S, et al. (2000) Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 95: 2240-2245. (Pubitemid 30167720)
35. Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, et al. (2003) Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood 102: 4255-4260. (Pubitemid 37494081)
36. D'Orsogna LJ, Roelen DL, Doxiadis, II, Claas FH (2010) Alloreactivity from human viral specific memory T-cells. Transpl Immunol 23: 149-155.
37. Wang LR, Dong LJ, Zhang MJ, Lu DP (2008) Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 42: 673-677.
38. Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, et al. (2010) Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant 16: 1309-1314.
39. Maltezou H, Kafetzis D, Abisaid D, Mantzouranis E, Chan K, et al. (2000) Viral infections in children undergoing hematopoietic stem cell transplant. Pediatr Infect Dis J 19: 307-312. (Pubitemid 30213069)
40. Kaneko T, Goldman W, Mellroth P, Steiner H, Fukase K, et al. (2004) Monomeric and polymeric Gram-negative peptidoglycan but not purified LPS stimulate the Drosophila IMD pathway. Immunity 20: 637-649. (Pubitemid 38638131)
41. Lampert IA, Moore RH, Huby R, Cohen J (1988) Observations on the role of endotoxin in graft-versus-host disease. Prog Clin Biol Res 272: 351-359.
42. Imado T, Iwasaki T, Kitano S, Satake A, Kuroiwa T, et al. (2010) The protective role of host Toll-like receptor-4 in acute graft-versus-host disease. Transplantation 90: 1063-1070.
43. Sivula J, Cordova ZM, Tuimala J, Jaatinen T, Partanen J, et al. (2012) Toll-like receptor gene polymorphisms confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantation. Scand J Immunol 76: 336-341.
44. van der Velden WJ, Blijlevens NM, Maas FM, Schaap NP, Jansen JH, et al. (2009) NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. Bone Marrow Transplant 44: 243-248.
45. Xun C, Tsuchida M, Thompson J (1997) Delaying transplantation after total body irradiation is a simple and effective way to reduce acute graft-versus-host disease mortality after major H2 incompatible transplantation. Transplantation 64: 297-302. (Pubitemid 27332676)
46. McCarthy PL Jr, Williams L, Harris-Bacile M, Yen J, Przepiorka D, et al. (1996) A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease. Transplantation 62: 626-631. (Pubitemid 26313906)
47. Antin J, Weisdorf D, Neuberg D, Nicklow R, Clouthier S, et al. (2002) Interleukin-1 blockade does not prevent acute graft-versust-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation. Blood 100: 3479-3482.
48. Jenq R, Ubeda C, Taur Y, Menezes C, Khanin R, et al. (2012) Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 209: 903-911.